Niagen Bioscience, Inc. Common Stock (NAGE) Stock Price, Quote & AI Analysis

Live NAGE stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Niagen Bioscience, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Niagen Bioscience, Inc. Common Stock (NAGE), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

NAGE
Niagen Bioscience, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
5.950000
High
6.180000
Low
5.950000
Volume
481,620
VWAP
-
Market Cap
$481,231,018.17
52W Range
$5.25 - $14.69
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 2, 2026 Q4
After Hours
EPS Estimate: $0.0224
Revenue Estimate: $32,339,100.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Niagen Bioscience, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Niagen Bioscience, Inc. Common Stock Overview

Company information

Company Overview

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Company Details
Market Cap
$488.41M
Shares Outstanding
79,806,136
Weighted Shares Outstanding
79,806,139
CEO
Robert N. Fried
Address
10900 WILSHIRE BLVD, LOS ANGELES, CA, 90024
Employees
104
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Niagen Bioscience, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...